BCH timeline
Every BCH batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| BCH-2607-H7307 | CJC-1295 with DAC | 07 Jul 2026 | 2026-Q3 | 7 | 97.92 | 1.06 | 98.12 | +0.20 | |
| BCH-2603-Y7018 | GHRP-6 | 28 Mar 2026 | 2026-Q2 | 5 | 98.61 | 0.81 | 98.79 | +0.18 | |
| BCH-2603-G6422 | BPC-157 | 10 Mar 2026 | 2026-Q3 | 5 | 98.37 | 0.74 | 98.63 | +0.26 | |
| BCH-2603-L7546 | BPC-157 | 03 Mar 2026 | 2026-Q3 | 2 | 97.74 | 0.94 | 97.60 | -0.14 | |
| BCH-2602-V8155 | Tirzepatide | 28 Feb 2026 | 2026-Q1 | 4 | 98.41 | 1.28 | 99.00 | +0.59 | |
| BCH-2602-E8253 | N-Acetyl Semax Amide | 22 Feb 2026 | 2026-Q3 | 4 | 97.47 | 0.31 | 98.00 | +0.53 | |
| BCH-2601-U7218 | MOTS-c | 26 Jan 2026 | 2026-Q1 | 1 | 98.40 | n<2 | 98.53 | +0.13 | |
| BCH-2601-S7929 | MOTS-c | 20 Jan 2026 | 2026-Q1 | 4 | 98.08 | 0.91 | 97.81 | -0.27 | |
| BCH-2601-N7656 | Tirzepatide | 07 Jan 2026 | 2026-Q1 | 8 | 97.57 | 1.17 | 98.00 | +0.43 | |
| BCH-2601-G7069 | MK-677 (Ibutamoren mesylate) | 07 Jan 2026 | 2026-Q1 | 14 | 97.93 | 1.29 | 98.28 | +0.35 | |
| BCH-2511-L5815 | MOTS-c | 28 Nov 2025 | 2026-Q2 | 2 | 97.00 | 0.08 | 97.29 | +0.29 | |
| BCH-2511-G7276 | MK-677 (Ibutamoren mesylate) | 13 Nov 2025 | 2026-Q2 | 13 | 98.35 | 0.99 | 98.61 | +0.26 | |
| BCH-2511-D7240 | MGF | 03 Nov 2025 | 2026-Q2 | 10 | 98.89 | 0.72 | 99.35 | +0.46 | |
| BCH-2510-P7196 | MK-677 (Ibutamoren mesylate) | 20 Oct 2025 | 2025-Q4 | 2 | 98.42 | 0.59 | 98.63 | +0.21 | |
| BCH-2510-P7043 | Ipamorelin | 10 Oct 2025 | 2026-Q1 | 2 | 99.35 | 0.30 | 99.50 | +0.15 | |
| BCH-2510-F6239 | Gonadorelin | 08 Oct 2025 | 2025-Q4 | 9 | 98.62 | 1.25 | 98.94 | +0.32 | |
| BCH-2509-A6666 | Cagrilintide | 29 Sep 2025 | 2025-Q4 | 6 | 99.31 | 0.68 | 99.50 | +0.19 | |
| BCH-2509-K6299 | AOD-9604 | 28 Sep 2025 | 2025-Q4 | 7 | 98.03 | 1.57 | 98.40 | +0.37 | |
| BCH-2509-E6436 | TB-500 | 02 Sep 2025 | 2026-Q1 | 1 | 98.90 | n<2 | 99.21 | +0.31 | |
| BCH-2508-H6138 | BPC-157 | 23 Aug 2025 | 2025-Q4 | 2 | 98.54 | 0.30 | 99.00 | +0.46 | |
| BCH-2508-P8402 | L-Glutathione (reduced) | 15 Aug 2025 | 2025-Q3 | 1 | 98.74 | n<2 | 99.27 | +0.53 | |
| BCH-2508-M6544 | GHRP-2 | 07 Aug 2025 | 2026-Q1 | 4 | 98.79 | 0.66 | 99.08 | +0.29 | |
| BCH-2508-A7737 | Tirzepatide | 04 Aug 2025 | 2025-Q3 | 4 | 98.52 | 0.24 | 99.00 | +0.48 | |
| BCH-2508-X6429 | L-Glutathione (reduced) | 01 Aug 2025 | 2025-Q3 | 12 | 97.62 | 1.84 | 97.60 | -0.02 | |
| BCH-2506-G6608 | Pemvidutide | 16 Jun 2025 | 2025-Q3 | 12 | 97.99 | 1.28 | 98.50 | +0.51 | |
| BCH-2506-D6485 | BPC-157 | 10 Jun 2025 | 2025-Q4 | 1 | 98.95 | n<2 | 99.49 | +0.54 | |
| BCH-2506-L7534 | GHRP-2 | 08 Jun 2025 | 2025-Q3 | 10 | 98.63 | 1.25 | 98.50 | -0.13 | |
| BCH-2505-Y7460 | Semaglutide | 25 May 2025 | 2025-Q4 | 10 | 98.21 | 1.54 | 98.28 | +0.07 | |
| BCH-2505-J6671 | MOTS-c | 13 May 2025 | 2025-Q2 | 5 | 98.17 | 0.81 | 98.37 | +0.20 | |
| BCH-2505-T7755 | CJC-1295 with DAC | 08 May 2025 | 2025-Q3 | 10 | 98.39 | 1.47 | 99.02 | +0.63 | |
| BCH-2504-B8049 | AOD-9604 | 15 Apr 2025 | 2025-Q3 | 4 | 98.85 | 0.66 | 98.87 | +0.02 | |
| BCH-2502-F7546 | Tirzepatide | 17 Feb 2025 | 2025-Q3 | 1 | 97.12 | n<2 | 97.81 | +0.69 | |
| BCH-2502-A6537 | CJC-1295 (no DAC) | 10 Feb 2025 | 2025-Q1 | 10 | 98.29 | 1.62 | 98.68 | +0.39 | |
| BCH-2502-Y7711 | L-Glutathione (reduced) | 05 Feb 2025 | 2025-Q2 | 3 | 98.23 | 0.83 | 98.39 | +0.16 | |
| BCH-2502-H6657 | PT-141 (Bremelanotide) | 01 Feb 2025 | 2025-Q2 | 11 | 99.31 | 1.37 | 99.25 | -0.06 | |
| BCH-2501-B6879 | Hexarelin | 24 Jan 2025 | 2025-Q2 | 6 | 97.85 | 0.72 | 98.47 | +0.62 | |
| BCH-2501-D6269 | Tirzepatide | 20 Jan 2025 | 2025-Q2 | 7 | 97.15 | 1.23 | 97.44 | +0.29 | |
| BCH-2412-Y7249 | Retatrutide | 10 Dec 2024 | 2025-Q2 | 2 | 97.08 | 0.65 | 96.84 | -0.24 | |
| BCH-2407-M6783 | Selank | 17 Jul 2024 | 2024-Q3 | 1 | 99.20 | n<2 | 99.67 | +0.47 | |
| BCH-2407-F6722 | Tirzepatide | 14 Jul 2024 | 2024-Q4 | 10 | 97.04 | 1.43 | 97.52 | +0.48 | |
| BCH-2406-X8001 | Semaglutide | 21 Jun 2024 | 2024-Q3 | 6 | 99.30 | 0.69 | 99.50 | +0.20 | |
| BCH-2406-Y6251 | BPC-157 | 16 Jun 2024 | 2024-Q3 | 13 | 98.06 | 1.06 | 99.00 | +0.94 | |
| BCH-2406-E7351 | CJC-1295 with DAC | 07 Jun 2024 | 2024-Q4 | 3 | 98.58 | 0.59 | 98.50 | -0.08 | |
| BCH-2405-R6960 | VIP | 18 May 2024 | 2024-Q3 | 2 | 97.56 | 0.48 | 98.00 | +0.44 | |
| BCH-2405-D8056 | Humanin (HNG) | 14 May 2024 | 2024-Q2 | 1 | 96.79 | n<2 | 97.26 | +0.47 | |
| BCH-2405-U6438 | Semaglutide | 02 May 2024 | 2024-Q2 | 14 | 97.74 | 1.40 | 98.00 | +0.26 | |
| BCH-2404-N7290 | Tirzepatide | 30 Apr 2024 | 2024-Q3 | 4 | 97.41 | 0.56 | 97.50 | +0.09 | |
| BCH-2402-K7631 | Semaglutide | 17 Feb 2024 | 2024-Q3 | 14 | 98.67 | 1.81 | 98.50 | -0.17 | |
| BCH-2402-C7117 | Cagrilintide | 01 Feb 2024 | 2024-Q2 | 6 | 98.07 | 2.32 | 98.13 | +0.06 | |
| BCH-2401-C7932 | Semaglutide | 20 Jan 2024 | 2024-Q2 | 12 | 98.09 | 1.67 | 98.53 | +0.44 | |
| BCH-2310-K7610 | Afamelanotide | 17 Oct 2023 | 2024-Q1 | 9 | 97.97 | 0.85 | 98.26 | +0.29 |